Entero Therapeutics, Inc. (NASDAQ:ENTO – Get Free Report) saw a significant growth in short interest in October. As of October 15th, there was short interest totalling 295,800 shares, a growth of 233.5% from the September 30th total of 88,700 shares. Based on an average daily volume of 814,900 shares, the short-interest ratio is currently 0.4 days. Approximately 6.4% of the shares of the stock are short sold.
Entero Therapeutics Stock Performance
ENTO stock traded down $0.05 during trading on Friday, hitting $0.63. The company had a trading volume of 105,785 shares, compared to its average volume of 374,309. The company has a 50-day simple moving average of $0.43. Entero Therapeutics has a 12 month low of $0.19 and a 12 month high of $14.51. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.21 and a quick ratio of 1.21.
About Entero Therapeutics
Further Reading
- Five stocks we like better than Entero Therapeutics
- How to Effectively Use the MarketBeat Ratings Screener
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Stock Market Upgrades: What Are They?
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Entero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.